Picard Medical reports Q1 2026 gross profit positive, executes $10.4M debt reduction
Picard Medical turned gross profit positive with 85% revenue growth to $1.2M in Q1 2026 while reducing debt by $10.4M through cash repayment and stock settlement. The company raised $5.0M in May 2026 offering and restructured warrants to strengthen capital structure amid NYSE American listing compliance efforts.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day